Related Experiment Video
Updated: Jun 29, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
A Case of Budd-Chiari Syndrome Secondary to Tumor Thrombosis
Nirmay Sonar1,2, Zaynah Sadiq1, Gurvinder Kaur1
1Internal Medicine, Norton Community Hospital, Norton, USA.
Insights
Budd-Chiari syndrome (BCS) caused by metastatic prostate cancer tumor thrombus is rare. This case highlights diagnosis and palliative management of this aggressive condition.
Area of Science:
- Hepatology
- Oncology
- Vascular Surgery
Background:
- Budd-Chiari syndrome (BCS) results from hepatic venous outflow obstruction.
- Prostate adenocarcinoma can metastasize and cause venous obstruction.
Observation:
- A 67-year-old male with prostate cancer presented with abdominal pain and an inferior vena cava (IVC) filling defect.
- Piflufolastat prostate-specific PET imaging confirmed tumor thrombosis in the IVC.
Findings:
- Metastatic prostate cancer can manifest as a tumor thrombus causing BCS.
- Diagnosis can be challenging, requiring advanced imaging like prostate-specific PET.
Implications:
- This case underscores the importance of considering metastatic disease in BCS diagnosis.
- Management requires a multidisciplinary approach, balancing aggressive therapy with quality of life, as demonstrated by the palliative care choice.
Abstract:
Budd-Chiari syndrome (BCS) is a rare constellation of conditions due to obstruction of venous flow from anatomical levels ranging from the hepatic veins to the confluence of the inferior vena cava (IVC) and right atrium. The resulting retrograde flow of blood leads to hepatomegaly, ascites, and liver failure among other features. Our case highlights the clinical features, diagnostic challenges, and management of a patient with a tumor thrombus from a metastatic prostate adenocarcinoma in a 67-year-old male leading to BCS. This patient, with a past history of prostate adenocarcinoma and aortic valve replacement on chronic warfarin anticoagulation, presented with acutely worsening abdominal pain and a distended abdomen, and imaging revealed an IVC filling defect. Subsequent imaging with a piflufolastat prostate-specific PET showing increased uptake in the IVC elucidated the diagnosis of tumor thrombosis. Management considerations include aggressive therapy and optimization of quality of life. The patient was offered both options, and options including surgical shunting, bypasses, and anticoagulation were discussed. After shared decision-making, the patient and family opted to choose the pathway of palliative radiation and anticoagulation.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

